Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin.
about
Intelligent design: combination therapy with oncolytic virusesCancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advancesEnhanced therapeutic efficacy by simultaneously targeting two genetic defects in tumors.Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cellsCombinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma.A novel sLRP6E1E2 inhibits canonical Wnt signaling, epithelial-to-mesenchymal transition, and induces mitochondria-dependent apoptosis in lung cancer.2-aminopurine enhances the oncolytic activity of an E1b-deleted adenovirus in hepatocellular carcinoma cells.Potentiation of tumor radiotherapy by a radiation-inducible oncolytic and oncoapoptotic adenovirus in cervical cancer xenografts.Molecular characterization of apoptosis induced by CARF silencing in human cancer cellsNegative regulation-resistant p53 variant enhances oncolytic adenoviral gene therapy.Downregulation of Mcl-1 synergizes the apoptotic response to combined treatment with cisplatin and a novel fiber chimeric oncolytic adenovirusDown-regulation of multiple cell survival proteins in head and neck cancer cells by an apoptogenic mutant of adenovirus type 5.Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach.Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy.A conditionally replicating adenovirus carrying interleukin-24 sensitizes melanoma cells to radiotherapy via apoptosis.The FANC pathway is activated by adenovirus infection and promotes viral replication-dependent recombination.Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers.Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy.Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo.The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11Potent antitumor effect of tumor microenvironment-targeted oncolytic adenovirus against desmoplastic pancreatic cancer.Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect.Decoy Wnt receptor (sLRP6E1E2)-expressing adenovirus induces anti-fibrotic effect via inhibition of Wnt and TGF-β signaling.Hepatocellular carcinoma-targeting oncolytic adenovirus overcomes hypoxic tumor microenvironment and effectively disperses through both central and peripheral tumor regions.
P2860
Q24628227-55F67C7A-4442-48F7-B9AB-9F5F6B63861FQ26863779-98561F05-7631-4CEE-9948-4FD7AF3F26C9Q33713001-175F8D8B-2ACB-488B-9AB7-C134F6B972C3Q34036114-624C54A8-3059-4939-BB84-3184357B61A8Q34238784-002FF08B-6B76-4B28-AF08-6A8502877E3CQ34273617-EFAF797E-01B4-4B8A-AF55-B66E0C24B1FDQ34764233-3B82E250-D4C8-4B43-BBC0-7DE90AFEC858Q35054432-87236390-2954-460C-9175-CD1603FFC654Q35092634-B53825B3-D07A-4D21-947B-084D6C060BA4Q36084467-710BB447-C95A-4DBC-A90F-0B700DF8766DQ36642630-3D8D0F48-B862-4BE6-95DF-D1F66DA0E3F0Q37414129-FBE3500E-6DBA-47C4-A621-760BD63582FDQ37867584-379B3212-33C3-446D-8F7B-B55C2A80E377Q37899223-AF18A2E1-2030-41D7-95E2-E36D022DB2FCQ37945288-76CCCCA8-86B4-4E61-B580-C145AC91F3B9Q39336014-D9FD482E-DDC3-4B79-9CA9-EDC47E625B2AQ39573277-F657648F-FEDD-48D8-B735-831094754CACQ39752863-99BB8D17-1600-454E-8146-AA41F2BBD946Q39775919-FBA1A776-32BF-4205-AFE8-B5C455C171C9Q39882822-B2C3B1B2-A70B-446D-A0DE-9A2C2FA7282EQ40913003-C81AF659-887C-4E53-AC32-3D4845CD318DQ41934085-77A364D1-37F7-46D9-8D31-750C6D65F9A6Q45863191-128DD6E9-C20E-4B34-8A60-0FA2603DADB5Q45885895-82752E85-B122-4F1D-9774-3B7BDDF7200AQ47117290-BBE2DF88-321D-4189-834C-DAF030238E4FQ49307189-DAC70A92-7B7B-4E3F-854A-C21F57685091
P2860
Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Markedly enhanced cytolysis by ...... in combination with cisplatin.
@en
type
label
Markedly enhanced cytolysis by ...... in combination with cisplatin.
@en
prefLabel
Markedly enhanced cytolysis by ...... in combination with cisplatin.
@en
P2093
P356
P1433
P1476
Markedly enhanced cytolysis by ...... in combination with cisplatin.
@en
P2093
A-Rum Yoon
Byeong-Woo Park
Hoguen Kim
Ji-Young Yoo
Joo-Hang Kim
Joo-Hyuk Sohn
Young-Sook Lee
P304
P356
10.1089/HUM.2006.17.379
P50
P577
2006-04-01T00:00:00Z